Behavioural phenotypes in the cuprizone model of central nervous system demyelination.
Animal models
Behavioural assays
Clinical symptoms
Cuprizone
Multiple sclerosis
Oligodendrocytosis
Journal
Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
02
05
2019
revised:
01
08
2019
accepted:
12
08
2019
pubmed:
24
8
2019
medline:
30
7
2020
entrez:
24
8
2019
Statut:
ppublish
Résumé
The feeding of cuprizone (CPZ) to animals has been extensively used to model the processes of demyelination and remyelination, with many papers adopting a narrative linked to demyelinating conditions like multiple sclerosis (MS), the aetiology of which is unknown. However, no current animal model faithfully replicates the myriad of symptoms seen in the clinical condition of MS. CPZ ingestion causes mitochondrial and endoplasmic reticulum stress and subsequent apoptosis of oligodendrocytes leads to central nervous system demyelination and glial cell activation. Although there are a wide variety of behavioural tests available for characterizing the functional deficits in animal models of disease, including that of CPZ-induced deficits, they have focused on a narrow subset of outcomes such as motor performance, cognition, and anxiety. The literature has not been systematically reviewed in relation to these or other symptoms associated with clinical MS. This paper reviews these tests and makes recommendations as to which are the most important in order to better understand the role of this model in examining aspects of demyelinating diseases like MS.
Identifiants
pubmed: 31442519
pii: S0149-7634(19)30369-0
doi: 10.1016/j.neubiorev.2019.08.008
pii:
doi:
Substances chimiques
Cuprizone
5N16U7E0AO
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
23-46Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.